Accessible Drug Label Provision Gets President’s Signature

On July 9, President Obama signed the Food and Drug Administration Safety and Innovation Act. This act includes provisions that will establish national best practices for pharmacies to use in providing accessible prescription drug labeling to their customers with vision loss. These provisions will serve as a valuable supplement to existing requirements under the Americans with Disabilities Act and other federal and state laws that obligate pharmacies to ensure effective communication and barrier removal for people with disabilities. See Sec. 904. Accessibility of information on prescription drug container labels by visually impaired and blind consumer at link above.